Leadscope Model Applier 2025.0 – New Features for Enhanced Predictive Toxicology

The latest release introduces advanced features to enhance toxicity prediction, improve data integration, and support in silico safety assessments.

Leadscope Model Applier (LMA) is a computational toxicology tool designed to support regulatory-compliant risk assessment through predictive modeling. The latest release version 2025.0 introduces advanced features to enhance toxicity prediction, improve data integration, and support in silico safety assessments.

Image: Leadscope Model Applier
Image 1: Leadscope Model Applier Version 2025.0

New Features and Enhancements

Toxicity Profiler

In silico profiling is a critical approach for understanding the toxicological characteristics of chemicals. The new Toxicity Profiler improves how data is summarized and organized, enabling a more structured interpretation of toxicological risk.

  • Aggregates and integrates experimental data and computational predictions across different mechanisms and observed effects.
  • Enhances early-stage screening in drug discovery by identifying potential toxicity concerns.
  • Supports read-across assessments by identifying structural features associated with specific toxicity endpoints.
  • Uses both statistical models and expert alerts to justify positive and negative predictions.

Image 2A: (Toxicity Profiler) Select relevant endpoints for profiling
Image 2B: (Toxicity Profiler) Review high-level toxicological profile to identify ‘hot spots’
Image 2C: (Toxicity Profiler) Dive deeper: assess data integration, confirm/refute results, and document findings within the tool

Database and Model Updates

Acute Toxicity Enhancements

To support regulatory toxicology and the 3Rs principles (replacement, reduction, refinement of animal testing), Leadscope has expanded its acute toxicity databases and models.

FeaturesDescription
Expanded datasetOver two thousand new acute toxicity records from ECHA REACH dossiers.
New modelsNew CLP statistical models and alerts predicting rat acute oral toxicity.
Regulatory supportExperimental data and predictive models align with GHS and CLP classifications to support risk assessment.

Image 3: Acute Rat Oral CLP Prediction

Skin Sensitization Model Enhancements

The skin sensitization model has been updated to improve the accuracy of predictions for regulatory applications, including extractables and leachables assessment, classification and labeling, and non-genotoxic impurity evaluations.

  • Hundreds of new chemical structures, incorporated from ECHA REACH dossiers.
  • Improved data transparency, including depicting inherited structure-activity relationship (SAR) calls.
  • Updated models with refined mechanistic insights to enhance predictions.

Bacterial Mutation Alerts Update

  • Improved mechanistic annotation for bacterial mutation predictions.
  • Updated alert definitions to increase confidence in identifying mutagenic potential.
  • Supports regulatory compliance with ICH M7 guidance.

N-Nitrosamine Read-Across Support

The Carcinogenic Potency Categorization Approach (CPCA) is a standard methodology used by health authorities to categorize n-nitrosamine impurities based on chemical structure and carcinogenic risk. Leadscope has now integrated CPCA within the Read-Across feature.

  • Aligns with the CPCA calculator used by global regulatory agencies.
  • Expands the ability to analyze n-nitrosamine compounds using read-across approaches.
  • Includes local similarity analysis to improve analog identification and enhance confidence in acceptable intake calculations.
Image 4: Read-Across

Optimizing Predictive Toxicology

The latest Leadscope Model Applier release offers more accurate predictions, improved transparency, and expanded databases to support regulatory risk assessment and computational toxicology.

Schedule a demo with us to find out more about the new features.

Instem Team

Instem is a leading supplier of SaaS platforms across Discovery, Study Management, Regulatory Submission and Clinical Trial Analytics. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.

Share This Article